Shareholder Robert Restrepo to sell 5,000 ACT (ACT) common shares

Rhea-AI Filing Summary

Robert Restrepo has filed a notice of proposed sale of 5,000 shares of the issuer’s common stock on NASDAQ through Fidelity Brokerage Services LLC. The filing lists an aggregate market value of $214,750.00 for these shares and an approximate sale date of February 11, 2026. As context, the number of common shares outstanding is shown as 144,395,767. Restrepo acquired the 5,000 shares in an open market purchase from the issuer on September 16, 2021, paid in cash.

The notice also discloses that during the past three months, Restrepo sold 2,562 and 7,438 common shares on November 18 and 19, 2025, for gross proceeds of $95,848.92 and $278,106.82, respectively. By signing, the seller represents that he is not aware of undisclosed material adverse information about the issuer’s operations.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5000	214750.00	144395767	02/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/16/2021	Open Market Purchase	Issuer			5000	09/16/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert Restrepo 8325 Six Forks Road Raleigh NC 27615	Common	11/18/2025	2562	95848.92
Robert Restrepo 8325 Six Forks Road Raleigh NC 27615	Common	11/19/2025	7438	278106.82

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing disclose for ACT?

The filing discloses that shareholder Robert Restrepo plans to sell 5,000 common shares of the ACT issuer on NASDAQ through Fidelity, with an aggregate market value of $214,750.00 and an approximate sale date of February 11, 2026.

How many ACT shares does Robert Restrepo plan to sell and at what value?

Robert Restrepo plans to sell 5,000 common shares of the ACT issuer. The Form 144 lists an aggregate market value of $214,750.00 for this planned sale, which is expected to take place on or around February 11, 2026 on NASDAQ.

When and how did the ACT shares in this Form 144 get acquired?

The 5,000 ACT issuer common shares were acquired on September 16, 2021 via an open market purchase from the issuer. The filing shows the full purchase price was paid in cash on the same date, with no installment or note arrangements disclosed.

What recent ACT share sales by Robert Restrepo are reported?

The filing reports two recent ACT issuer common stock sales by Robert Restrepo. On November 18, 2025 he sold 2,562 shares for $95,848.92, and on November 19, 2025 he sold 7,438 shares for $278,106.82 in gross proceeds.

How many ACT common shares are outstanding according to this notice?

The Form 144 states that 144,395,767 common shares of the ACT issuer are outstanding. This figure provides context for the planned sale of 5,000 shares, indicating the relative size of the transaction compared with the issuer’s total outstanding common stock.

What representation does the seller make about ACT’s information in this Form 144?

By signing the notice, the seller represents that he does not know any material adverse information about the ACT issuer’s current or prospective operations that has not been publicly disclosed, consistent with the standard representation language included in Form 144.